Skip to main content
OpenTrials
Completed

NCT Number: NCT04185064

Cryopneumatic Device After Shoulder Surgeries

This study randomize patients to receive either a cryopneumatic device or standard care (ice and ice packs) following open or arthroscopic shoulder surgeries. The primary objective is to determine the impact of the cryopneumatic device on post-surgery pain management, while secondary objectives are to detemine the effect on pain, patient eperience, quality of life, narcotic consumption and time to stop narcotic usage. Patients who do not wish to participate in the randomized portion of the trial will be invited to participate in an observational cohort who will all receive the cryopneumatic device. Patients who wish to enter this cohort will not have the device provided to them for free, and will either use their insurance or pay for the device, in order to determine if patients who pay demonstrate different outcomes from the patients receiving the device for free in the RCT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Shoulder Injuries Shoulder Disease Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brantford General Hospital, Brantford, Ontario, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • men or women aged 18 years and older;
  • undergoing a unilateral primary or revision shoulder surgery (total shoulder replacement or arthroscopic surgery [rotator cuff repair, subacromial decompression, Bankart repair, Latarjet repair, debridement]).

Exclusion criteria

  • patients undergoing bilateral surgery;
  • patients who are pregnant or nursing;
  • patients that do not believe they can comply with the study protocol;
  • patients generally unfit for surgery;
  • patients with specific treatment preferences;
  • patients who are unable to complete questionnaires due to language barriers, decreased mental capacity, neuro-psychological problems;
  • social factors precluding follow-up; 8) inability or unwillingness to provide informed consent.

Treatment and study plan

Game Ready ATX shoulder wrap; Game Ready GRPro 2.1

Device

the Game Ready ATX shoulder wrap that is anatomically engineered for the shoulder joint. The wrap is connected to the Game Ready GRPro 2.1 system enabling the integrated delivery of continuous cold and intermittent pneumatic compression therapy to the shoulder joint and surrounding soft tissues.

Standard care

Other

Participants will undergo post-surgical cryotherapy using the treating surgeons preferred method of cryotherapy, which can include rest, ice, and compression using standard ice packs or bag of ice, a cryocuff, or other such device.

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    Time frame: 12 weeks

    The NPRS measures pain severity on an 11-item scale (0 to 10). The patients will be asked to choose a number from 0 to 10 that best describes their current pain. 0 would mean "no pain" and 10 would mean "worst possible pain".

Secondary outcomes

  1. Narcotic Consumption

    Time frame: 12 weeks

    Narcotic usage will be measured based on the number of narcotics consumed during the study period and the time to cease narcotic use. Details of administration will be collected and recorded on the Medication Log CRF.

  2. European Quality of Life measure (EQ-5D)

    Time frame: 12 weeks

    The European Quality of Life measure EQ-5D comprises 5 dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) which are used to calculate a health status score from 0 (worst health) to 1 (best health). The EQ-5D also has a 0 (worst health) to 1 (best health) visual analog scale component.

  3. Net Promoter Score

    Time frame: 12 weeks

    Patient experience will be measured using the Net Promoter Score. Patients will rate their experience on a simple 0 (worst) to 10 (best) scale. Responses are classified into 3 groups (promotors, passives, and distractors). The Net Promoter Score is the percentage of promoters minus the percentage of detractors.

  4. Number of patients with adverse events; number of adverse events

    Time frame: 12 weeks

    All adverse events will be monitored and recorded on the Adverse Event CRF.

Sponsors and collaborators

Lead sponsor

Encore Research Inc.

Industry

Collaborators

  • CoolSystems, Inc.

Registry information

Official study title

Randomized-Controlled Trial and Evaluation Cohort Study of Patients Using a Cryopneumatic Device After Open or Arthroscopic Shoulder Surgeries

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Dec 4, 2019
Registry last updated
Feb 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.